Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 701-710 of 9468

Page
per page
  1. Levodopa
    A8460 Levodopa
    Summary: Dopamine precursor.
      insoluble in DMSO; insoluble in EtOH; ≥6.57 mg/mL
  2. L-Glutamine
    A8461 L-Glutamine
    Summary: Non-essential amino acid
      insoluble in EtOH; insoluble in DMSO; ≥6.2 mg/mL
  3. Lithium Citrate
    A8462 Lithium Citrate
    Summary: Mood stabilizer
      insoluble in EtOH; ≥14.1 mg/mL
  4. Lithocholic Acid
    A8463 Lithocholic Acid
    Target: Farnesoid X receptors (FXRs)|Vitamin D receptors (VDRs)|Pregnane X receptor(PXR)
    Summary: Toxic secondary bile acid; induces intrahepatic cholestasis; FXR antagonist and PXR/SXR agonist
      insoluble in H2O; ≥12.95 mg/mL
  5. LY2109761
    A8464 LY2109761
     4 Citation
    Summary: TβRI/II kinase inhibitor
      ≥22.1 mg/mL
  6. Meloxicam (Mobic)
    A8466 Meloxicam (Mobic)
    Target: COX
    Summary: Nonsteroidal anti-inflammatory drug
      insoluble in H2O; insoluble in EtOH; ≥17.57 mg/mL
  7. Bexarotene
    A8380 Bexarotene
    Target: Retinoid X receptors (RXR)
    Summary: Retinoid Receptor agonist
      insoluble in H2O; ≥10.35 mg/mL
  8. BIBR-1048
    A8381 BIBR-1048
    Summary: Thrombin inhibitor
      ≥30 mg/mL
  9. Bismuth Subsalicylate
    A8382 Bismuth Subsalicylate
    Summary: Prostaglandin G/H Synthase 1/2 inhibitor
      insoluble in H2O; insoluble in EtOH; insoluble in DMSO
  10. Mepenzolate Bromide
    A8467 Mepenzolate Bromide
    Target: AChR
    Summary: mAChR antagonist

Items 701-710 of 9468

Page
per page